Pharmacogenomics in clinical practice: reality and expectations
- PMID: 21931473
- PMCID: PMC3171815
Pharmacogenomics in clinical practice: reality and expectations
Figures


References
-
- Freuh Felix W. Real-world clinical effectiveness, regulatory transparency, and payer coverage: Three ingredients for translating pharmacogenomics into clinical practice. Pharmacogenomics. 2010;11(5):657–660. - PubMed
-
- Trent RJ. Pathology practice and pharmacogenomics. Pharmacogenomics. 2010;11(1):105–111. - PubMed
-
- Gervasini G, Benítez J, Carrillo JA. Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy. Eur J Clin Pharmacol. 2010;66(8):755–774. - PubMed
-
- Vijverberg SJ, Pieters T, Cornel MC. Ethical and social issues in pharmacogenomics testing. Curr Pharm Des. 2010;16(2):245–252. - PubMed
-
- Squassina A, Manchia M, Manolopoulos VG, et al. Realities and expectations of pharmacogenomics and personalized medicine: Impact of translating genetic knowledge into clinical practice. Pharmacogenomics. 2010;11(8):1149–1167. - PubMed
LinkOut - more resources
Full Text Sources